Dr. Ravi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3466
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2018 - 2020
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2015 - 2018
- University of Cambridge School of MedicineClass of 2012
Certifications & Licensure
- MA State Medical License 2018 - 2025
- MN State Medical License 2017 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate Cancer.Praful Ravi, Lucia Kwak, Andres M Acosta, Saahil Rastogi, Wanling Xie
European Urology. 2025-02-06 - 3 citationsRefining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials.Praful Ravi, Wanling Xie, Marc Buyse, Susan Halabi, Philip W Kantoff
European Urology. 2025-02-01 - Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer.Praful Ravi, Wanling Xie, Silke Gillessen, Bertrand Tombal, Daniel E Spratt
Prostate Cancer and Prostatic Diseases. 2025-01-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: